Uploaded August 2026 | Updated September 2026, 2 weeks ago

---

A landmark study published in the latest issue of The Lancet—one of the world's most prestigious medical journals—offers a beacon of hope for those battling advanced hepatocellular carcinoma (HCC).

The research, led by a team from Zhongshan Hospital, Fudan University, reveals that surgical resection following effective immunotherapy may significantly prolong tumor-free survival in select patients.

The findings have the potential to reshape global clinical practice—offering a curative pathway where few existed before.

__________________
ShanghaiEye focuses on producing top-quality contents.
Nobody knows SHANGHAI better than us.
Please subscribe to us ☻☻☻
__________________
For more stories, please click

■ What's up today in Shanghai, the most updated news of the city
youtube.com/playlist?list=PLeyl7CQ2A5MNjpE4hspSVry8dR555getN

■ Amazing Shanghai, exploring the unknown corners of the city, learning the people, food and stories behind them
youtube.com/playlist?list=PLeyl7CQ2A5MMVTWr-zIXjsS4hhSQPmyes

■ What Chinese people's lives are like during the post COVID-19 period
youtube.com/playlist?list=PLeyl7CQ2A5MPrPTmIirpfgETu6VKVESXe

■ Views of foreign scholars on China and its affairs
youtube.com/playlist?list=PLeyl7CQ2A5MO9ua_nSK6slRPdUl-ovjRe

■ Foreign faces in Shanghai, people living in this city sharing their true feelings
youtube.com/playlist?list=PLeyl7CQ2A5MP0vJDSw23_1MCPJhAfGbiG

■ Mini-docs showing why China is the country it is today
youtube.com/playlist?list=PLeyl7CQ2A5MOreRu2AbZ3ziIUyCcdBLwX

__________________
☎Leave us messages if you have any suggestions or questions!
Thank you!